RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+16.36%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.73B
AUM Growth
+$1.73B
(+16%)
Cap. Flow
+$54.9M
Cap. Flow
% of AUM
3.17%
Top 10 Holdings %
Top 10 Hldgs %
27.21%
Holding
142
New
9
Increased
33
Reduced
17
Closed
2
Top Buys
| 1 |
Humana
HUM
|
$27.3M |
| 2 |
Johnson & Johnson
JNJ
|
$21.8M |
| 3 |
Pacira BioSciences
PCRX
|
$13.1M |
| 4 |
AFAM
Almost Family Inc
AFAM
|
$10.9M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$10.3M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$28.2M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$21.3M |
| 3 |
Aclaris Therapeutics
ACRS
|
$12.7M |
| 4 |
Medpace
MEDP
|
$4.87M |
| 5 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$3.19M |
Sector Composition
| 1 | Healthcare | 82.21% |
| 2 | Financials | 2.45% |
| 3 | Consumer Discretionary | 0.63% |
| 4 | Industrials | 0.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Novavax
NVAX
$1.21B
| $1.05M | 0.06% | 820,000 | – | – |
|
127
Perrigo
PRGO
$3.27B
| $1.04M | 0.06% | 15,600 +6,300 | +68% | +$418K |
|
128
Dynavax Technologies
DVAX
$1.19B
| $982K | 0.06% | 165,000 | – | – |
|
|
INFI
129
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $872K | 0.05% | 270,000 | – | – |
|
|
CHMA
130
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $837K | 0.05% | 492,500 | – | – |
|
131
Bausch Health
BHC
$2.74B
| $732K | 0.04% | 66,400 -5,000 | -7% | -$55.1K |
|
132
Tandem Diabetes Care
TNDM
$845M
| $714K | 0.04% | 595,000 | – | – |
|
|
OREX
133
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $569K | 0.03% | 165,300 | – | – |
|
|
ANTH
134
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $552K | 0.03% | 1,296,568 +916,568 | +241% | +$390K |
|
135
Dare Bioscience
DARE
$27.2M
| $508K | 0.03% | 625,000 | – | – |
|
|
DMTX
136
DELISTED
Dimension Therapeutics, Inc
DMTX
| $475K | 0.03% | 271,370 | – | – |
|
|
137
Medpace
MEDP
$13.4B
| – | – | -135,000 | Closed | -$4.87M |
|
|
ARIA
138
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – | -250,000 | Closed | -$3.11M |
|